Role of adjuvant chemotherapy in malignant mucosal melanoma of the head and neck

Oral Oncology

Volumn 46, Issue 8, 2010, Pages 607-611

  Ahn, Heui June ^a,b   Na, Im Ii ^a   Park, Yeon Hee ^a,c   Cho, Soo Youn ^a   Lee, Byeong Cheol ^a   Lee, Guk Haeng ^a   Koh, Jae Soo ^a   Lee, Yong Sik ^a   Shim, Yoon Sang ^a   Kim, Yong Kack ^a   Kang, Hye Jin ^a   Ryoo, Baek Yeol ^a,b   Yang, Sung Hyun ^a  

^a Korea Cancer Center Hospital   (South Korea)

^b Asan Medical Center   (South Korea)

^c Samsung Medical Center   (South Korea)

Author keywords

Adjuvant chemotherapy; Head and neck; Mucosal melanoma

Indexed keywords

CARMUSTINE; CISPLATIN; DACARBAZINE; LOMUSTINE; PROTEIN MDM2; PROTEIN P53; TAMOXIFEN; VINCRISTINE;

ADJUVANT THERAPY; ADULT; AGE DISTRIBUTION; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALOPECIA; ANEMIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; FEBRILE NEUTROPENIA; FEMALE; GENDER; HEAD AND NECK CANCER; HEAD AND NECK MUCOSAL MELANOMA; HUMAN; HUMAN TISSUE; LEUKOPENIA; MALE; MEDICAL RECORD REVIEW; MULTIPLE CYCLE TREATMENT; MYALGIA; NAUSEA; NEUROPATHY; NEUTROPENIA; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SAMPLE SIZE; SIDE EFFECT; TASK PERFORMANCE; THROMBOCYTOPENIA; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MELANOMA; MIDDLE AGED; MOUTH MUCOSA; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 77955516339     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2010.05.005     Document Type: Article

References (32)

1. A.E. Chang, L.H. Karnell, and H.R. Menck The national cancer data base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American college of surgeons commission on cancer and the American cancer society Cancer 83 1998 1664 1678
2. J.M. Owens, D.B. Roberts, and J.N. Myers The role of postoperative adjuvant radiation therapy in the treatment of mucosal melanomas of the head and neck region Arch Otolaryngol Head Neck Surg 129 2003 864 868
3. S. Manolidis, and P.J. Donald Malignant mucosal melanoma of the head and neck: review of the literature and report of 14 patients Cancer 80 1997 1373 1386
4. M.L. Prasad, S.G. Patel, A.G. Huvos, J.P. Shah, and K.J. Busam Primary mucosal melanoma of the head and neck: a proposal for microstaging localized, stage I (lymph node-negative) tumors Cancer 100 2004 1657 1664
5. J.P. Shah, A.G. Huvos, and E.W. Strong Mucosal melanomas of the head and neck Am J Surg 134 1977 531 535
6. A. Breslow Tumor thickness, level of invasion and node dissection in stage I cutaneous melanoma Ann Surg 182 1975 572 575
7. C.L. Day Jr., R.A. Lew, M.C. Mihm Jr., M.N. Harris, A.W. Kopf, and A.J. Sober et al. The natural break points for primary-tumor thickness in clinical stage I melanoma N Engl J Med 305 1981 1155
8. S. Temam, G. Mamelle, P. Marandas, P. Wibault, M.F. Avril, and F. Janot et al. Postoperative radiotherapy for primary mucosal melanoma of the head and neck Cancer 103 2005 313 319
9. J.J. Yeh, M.R. Weiser, J. Shia, and W.J. Hwu Response of stage IV anal mucosal melanoma to chemotherapy Lancet Oncol 6 2005 438 439
10. S.G. Patel, M.L. Prasad, M. Escrig, B. Singh, A.R. Shaha, and D.H. Kraus et al. Primary mucosal malignant melanoma of the head and neck Head Neck 24 2002 247 257
11. M.L. Prasad, K.J. Busam, S.G. Patel, S. Hoshaw-Woodard, J.P. Shah, and A.G. Huvos Clinicopathologic differences in malignant melanoma arising in oral squamous and sinonasal respiratory mucosa of the upper aerodigestive tract Arch Pathol Lab Med 127 2003 997 1002
12. M.L. Prasad, S. Patel, S. Hoshaw-Woodard, M. Escrig, J.P. Shah, and A.G. Huvos et al. Prognostic factors for malignant melanoma of the squamous mucosa of the head and neck Am J Surg Pathol 26 2002 883 892
13. D.C. Whiteman, P.G. Parsons, and A.C. Green P53 expression and risk factors for cutaneous melanoma: a case-control study Int J Cancer 77 1998 843 848
14. E.L. Kaplan, and M.P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
15. D.R. Cox Regression models and life-tables J R Stat Soc [B] 44 1972 793 797
16. R. Brookmeyer, and J. Crowley A confidence interval for median survival time Biometrics 38 1982 29 41
17. A.D. Rapidis, C. Apostolidis, G. Vilos, and S. Valsamis Primary malignant melanoma of the oral mucosa J Oral Maxillofac Surg 61 2003 1132 1139
18. N.W. Yii, T. Eisen, M. Nicolson, R. A'Hern, P. Rhys-Evans, and D. Archer et al. Mucosal malignant melanoma of the head and neck: the Marsden experience over half a century Clin Oncol (R Coll Radiol) 15 2003 199 204
19. S.P. Lee, K.T. Shimizu, L.M. Tran, G. Juillard, and T.C. Calcaterra Mucosal melanoma of the head and neck: the impact of local control on survival Laryngoscope 104 1994 121 126
20. M. Nakaya, M. Mochiki, S. Takeuchi, T. Yuge, K. Nakao, and N. Nakamura et al. Malignant melanoma of nasal cavity: report of 16 Japanese patients Auris Nasus Larynx 31 2004 233 237
21. J.A. Regezi, J.R. Hayward, and T.N. Pickens Superficial melanomas of oral mucous membranes Oral Surg Oral Med Oral Pathol 45 1978 730 740
22. G.B. Snow, and I. van der Waal Mucosal melanomas of the head and neck Otolaryngol Clin North Am 19 1986 537 547
23. H. Wada, K. Nemoto, Y. Ogawa, M. Hareyama, H. Yoshida, and A. Takamura et al. A multi-institutional retrospective analysis of external radiotherapy for mucosal melanoma of the head and neck in Northern Japan Int J Radiat Oncol Biol Phys 59 2004 495 500
24. M.R. Hussein, A.K. Haemel, and G.S. Wood P53-related pathways and the molecular pathogenesis of melanoma Eur J Cancer Prev 12 2003 93 100
25. M. Pandey, A. Mathew, E.M. Iype, P. Sebastian, E.K. Abraham, and K.M. Nair Primary malignant mucosal melanoma of the head and neck region: pooled analysis of 60 published cases from India and review of literature Eur J Cancer Prev 11 2002 3 10
26. D. Polsky, B.C. Bastian, C. Hazan, K. Melzer, J. Pack, and A. Houghton et al. HDM2 protein overexpression, but not gene amplification, is related to tumorigenesis of cutaneous melanoma Cancer Res 61 2001 7642 7646
27. D. Polsky, K. Melzer, C. Hazan, K.S. Panageas, K. Busam, and M. Drobnjak et al. HDM2 protein overexpression and prognosis in primary malignant melanoma J Natl Cancer Inst 94 2002 1803 1806
28. C. Gwosdz, K. Scheckenbach, O. Lieven, J. Reifenberger, A. Knopf, and H. Bier et al. Comprehensive analysis of the p53 status in mucosal and cutaneous melanomas Int J Cancer 118 2005 577 582
29. S. Ilmonen, M. Hernberg, S. Pyrhonen, J. Tarkkanen, and S. Asko-Seljavaara Ki-67, Bcl-2 and p53 expression in primary and metastatic melanoma Melanoma Res 15 2005 375 381
30. Y. Kakehi, E. Ozdemir, T. Habuchi, H. Yamabe, T. Hashimura, and Y. Katsura et al. Absence of p53 overexpression and favorable response to cisplatin-based neoadjuvant chemotherapy in urothelial carcinomas Jpn J Cancer Res 89 1998 214 220
31. W.S. el-Deiry Role of oncogenes in resistance and killing by cancer therapeutic agents Curr Opin Oncol 9 1997 79 87
32. M.A. Brantley Jr., and J.W. Harbour Deregulation of the Rb and p53 pathways in uveal melanoma Am J Pathol 157 2000 1795 1801